Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas

Sarcomas are a heterogeneous group of rare malignancies originating from mesenchymal tissues with limited therapeutic options. Recently, alterations in components of the fibroblast growth factor receptor (FGFR) signaling pathway have been identified in a range of different sarcoma subtypes, most not...

Descripción completa

Detalles Bibliográficos
Autores principales: Napolitano, Andrea, Ostler, Alexandra E., Jones, Robin L., Huang, Paul H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235236/
https://www.ncbi.nlm.nih.gov/pubmed/34204560
http://dx.doi.org/10.3390/cells10061533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235236/
https://www.ncbi.nlm.nih.gov/pubmed/34204560
http://dx.doi.org/10.3390/cells10061533

Ejemplares similares